Semax¶
Identification¶
| Property | Value |
|---|---|
| CAS Number | 80714-61-0 |
| Molecular Formula | C37H51N9O10S |
| Molecular Weight | ~813.9 Da |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro-OH |
| Amino Acid Count | 7 (ACTH(4-7) + Pro-Gly-Pro C-terminal) |
| Appearance | White to off-white lyophilized powder |
| Purity Standard | ≥99% by HPLC |
| Solubility | Soluble in sterile water or PBS |
| Storage | 2-8°C, desiccated, protect from light |
Category: Nootropic & Anti-Aging
Catalog SKU: PSH-SEMAX-10MG
Research Background¶
Semax is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It consists of the ACTH(4-7) fragment (Met-Glu-His-Phe) - the active core of adrenocorticotropic hormone that mediates neurotrophic effects without steroidogenic activity - extended with a C-terminal Pro-Gly-Pro tripeptide. Semax is the most extensively characterized nootropic peptide in the literature, with documented effects on BDNF and NGF expression, cognitive function, and neuroprotection across multiple paradigms.
Key Mechanisms¶
| Mechanism | Details |
|---|---|
| BDNF/NGF Upregulation | Enhanced transcription of neurotrophins → synaptic plasticity |
| Melanocortin Receptor | MC4/MC5 receptor agonism → cAMP → CREB-mediated neurotrophin gene expression |
| C-terminal PGP Motif | Pro-Gly-Pro extension enhances metabolic stability and BBB penetration |
| Anti-Inflammatory | Reduced microglial activation; decreased IL-1β and TNF-α in CNS |
Research Focus Areas¶
Neuroprotection¶
Ischemia/hypoxia models - neuronal survival enhancement
Cognitive Enhancement¶
Learning & memory consolidation in rodent models
BDNF/NGF Upregulation¶
Neurotrophin expression - synaptic plasticity support
Stroke Recovery¶
Post-ischemic neurological function improvement
Optic Nerve Protection¶
Retinal ganglion cell survival in glaucoma models
Available Configurations¶
| Configuration | Content | Best For |
|---|---|---|
| Standard Kit | 10 mg × 10 vials | Neuroprotection studies; evaluation |
| Bulk Kit | 30 mg × 10 vials | Chronic cognitive models; repeat orders |
| Custom | Custom mg × custom vials | OEM; private-label |
Tiered Wholesale Pricing¶
| Volume | Discount | For |
|---|---|---|
| 1 kit | List price | Evaluation; competitive analysis |
| 5+ kits | 10% off | Initial portfolio expansion |
| 20+ kits | 20% off | Mid-size distributors |
| 50+ kits | 30% off | Regional distributors |
Quality Specifications¶
| Parameter | Method | Criterion |
|---|---|---|
| Purity | HPLC at 214 nm, C18 column | ≥99.0% peak area |
| Identity (MW) | ESI-MS | ~813.9 ± 1.0 Da |
| Appearance | Visual inspection | White to off-white powder |
| Peptide Content | Amino acid analysis | ≥80% net peptide |
| Met Oxidation | HPLC-MS | Met(O) ≤ 1% |
Frequently Asked Questions¶
Q1: What is Semax and how does it relate to ACTH?¶
Semax is a synthetic heptapeptide based on ACTH(4-7), the N-terminal fragment of ACTH that mediates neurotrophic effects without adrenal steroidogenesis. The C-terminal Pro-Gly-Pro extension confers metabolic stability and CNS penetration.
Q2: What is the mechanism of Semax's cognitive effects?¶
Semax primarily upregulates BDNF and NGF via melanocortin receptor activation. Elevated neurotrophins support synaptic plasticity, neuronal survival, and cognitive function. Additional effects include anti-inflammatory microglial modulation and improved cerebral blood flow.
Q3: How does the Pro-Gly-Pro extension work?¶
The C-terminal PGP tripeptide protects from carboxypeptidase degradation and enhances blood-brain barrier penetration. The Pro-Gly-Pro sequence itself has reported glyproline activity that may contribute to neuroprotection.
Q4: How does Semax differ from Selank?¶
Both are Russian-developed nootropics with distinct mechanisms. Semax (ACTH-derived) → melanocortin receptors → BDNF/NGF → cognition. Selank (tuftsin-derived) → GABAergic/dopaminergic → anxiolysis. Complementary: Semax for cognition, Selank for anxiety.
Q5: What purity and QC is provided for Semax?¶
≥99% HPLC with ESI-MS identity. Special QC: Met(O) content ≤ 1% (N-terminal methionine is oxidation-sensitive). Batch-specific COA included.
Key Research References¶
| Reference | PMID | Key Finding |
|---|---|---|
| Dolotov OV et al. "Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus." Brain Res. 2006;1117(1):54–60. | 16996037 | Semax upregulated BDNF and trkB in hippocampus via melanocortin receptor activation; mechanism for cognitive-enhancing effects |
| Glazova NY et al. "Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in rats." Eur J Pharmacol. 2021;892:173771. | 33418449 | Semax attenuates behavioral and neurochemical alterations, supporting neuroprotective and cognitive-preserving effects |
Stability & Storage¶
| Condition | Degradation Profile |
|---|---|
| Lyophilized Storage | Standard peptide stability; 24 months at 2-8°C in desiccated environment, protect from light |
| Met1 Oxidation Sensitivity | N-terminal methionine is oxidation-sensitive; Met(O) content monitored at ≤1% in every batch. Protect from oxidants and direct light |
| Pro-Gly-Pro Stability | The C-terminal PGP tripeptide confers enhanced metabolic stability and BBB penetration |
| Neutral pH (6.0-7.5) | Stable; recommended for reconstitution in sterile water or PBS |
| Reconstituted Solution | 24 h at 2-8°C; aliquot and freeze at -20°C for extended use. Avoid repeated freeze-thaw |
Source & Purchase¶
For research-grade SEMAX and related compounds in this category, visit the PeptideSourceHub category page for bulk pricing and available specifications.
Browse SEMAX & Related Products →
Related Products¶
| Product | Link |
|---|---|
| Selank | selank.md - Tuftsin-derived anxiolytic peptide |
| DSIP | dsip.md - Delta sleep-inducing peptide |
| Epithalon | epithalon.md - Pineal tetrapeptide for longevity |
| FOXO4-DRI | foxo4-dri.md - Senolytic peptide for cellular senescence |